Dr Charlotte Nodlaig O'tiarnaigh, PHD | |
514 8th Ave, Asbury Park, NJ 07712-5206 | |
(732) 660-0116 | |
Not Available |
Full Name | Dr Charlotte Nodlaig O'tiarnaigh |
---|---|
Gender | Female |
Speciality | Clinical Psychologist |
Experience | 27 Years |
Location | 514 8th Ave, Asbury Park, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639372964 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | SIOO3700 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Charlotte Nodlaig O'tiarnaigh, PHD 514 8th Ave, Asbury Park, NJ 07712-5206 Ph: (732) 660-0116 | Dr Charlotte Nodlaig O'tiarnaigh, PHD 514 8th Ave, Asbury Park, NJ 07712-5206 Ph: (732) 660-0116 |
News Archive
The Johns Hopkins University School of Medicine, San Lucas Medical, a leading London-based medical education communications company and medical publisher of fifteen medical journals throughout Europe and Asia and MDSNe, a healthcare specific, social media startup, announced today their partnership to design, implement and distribute medical education to European healthcare providers based on social learning.
A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a University of South Florida Health (USF Health) Morsani College of Medicine research team reports.
Twenty-four month findings from IMPROVE HF, (The Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting), funded by Medtronic, Inc., demonstrated that clinics using the process improvement program increased adherence to evidence-based, guideline-recommended care by 82 and 62 percent, respectively, for cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) use, and 80 percent for aldosterone antagonist use, all relative to baseline results.
News outlets report on trends in the primary care workforce, including medical homes and concierge medicine.
› Verified 3 days ago